Results 11 to 20 of about 39,898 (187)
Applied Sciences, 2022 The aim of this study was to investigate levetiracetam pharmacokinetics in critically ill adult intensive care patients and to identify pathophysiological factors affecting its kinetics.
Sophia-Liberty Markantonis +6 more
doaj +1 more source
Stability of levetiracetam oral solution repackaged in oral plastic syringes [PDF]
, 2013 Purpose The long-term stability of levetiracetam solution in oral syringes was investigated in order to define a suitable beyond-use date and demonstrate the feasibility of storing prepared syringes for extended periods as an alternative to commercial ...
Hughes, Susan +2 more
core +2 more sources
Levetiracetam in clinical practice: efficacy and tolerability in epilepsy. [PDF]
, 2010 BACKGROUND: The aim of this study was to evaluate efficacy and tolerability of levetiracetam (LEV) in patients with different epilepsy syndromes. METHODS: We evaluated epileptic patients seen in the previous 18 months, including all patients with present
BILO, LEONILDA, de Leva MF, Meo R.
core +1 more source
Levetiracetam-induced rage and suicidality: Two case reports and review of literature
Epilepsy and Behavior Case Reports, 2015 Background: Levetiracetam-induced rage is a rare neurobehavioral adverse effect of levetiracetam that is characterized by seething rage, uncontrollable anger, fits of fury, depression, violence, and suicidal tendencies.
Orakwue A. Molokwu +2 more
doaj +1 more source
Frontiers in Veterinary Science, 2021 Limited information is available on the long-term follow-up and seizure recurrence in dogs with reactive seizures due to suspected exogenous toxicity.
Fabio Stabile, Luisa De Risio
doaj +1 more source
2015 ACVIM Small Animal Consensus Statement on Seizure Management in Dogs [PDF]
, 2016 This report represents a scientific and working clinical consensus statement on seizure management in dogs based on current literature and clinical expertise.
Bunch SE +37 more
core +2 more sources
Advance on synthesis, pharmacokinetics, and pharmacodynamics of the anti-epileptic drug: Levetiracetam [PDF]
E3S Web of Conferences, 2020 Over the past few decades, many patients around the world have suffered from epilepsy, and epilepsy treatment is a long-term process. Thus, the safety and efficacy of medication for epilepsy are of equal importance.
Wang Wei
doaj +1 more source
Effects of Levetıracetam Treatment on the Autonomic Nervous System Functions in Epilepsy Patients
Archives of Epilepsy, 2020 Objectives:Sudden unexpected death in epilepsy patients is considered to be the most significant epilepsy-related cause of death, and this is associated especially with uncontrolled generalized tonic-clonic seizures, cardiac arrhythmia, decreased heart ...
Dilek YILMAZ, Burhanettin ÇİĞDEM
doaj +1 more source
Multiple acquired portosystemic shunts in a cat secondary to chronic diaphragmatic rupture [PDF]
, 2015 A cat with a chronic diaphragmatic rupture presented with neurological signs, including twitching and focal seizures. Blood ammonia level was markedly elevated and therefore neurological signs were thought to be related to hepatic encephalopathy ...
Birchard SJ +3 more
core +3 more sources
Health Technology Assessment, 2021 Background: Levetiracetam (Keppra®, UCB Pharma Ltd, Slough, UK) and zonisamide (Zonegran®, Eisai Co. Ltd, Tokyo, Japan) are licensed as monotherapy for focal epilepsy, and levetiracetam is increasingly used as a first-line treatment for generalised ...
Anthony G Marson +18 more
doaj +1 more source